| Fiscal Year End | Company Status | Exempt Flag |
| July 31 | Trading | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 12/Jul/2010 | | Canada | | |
|
|
| Exchange Filing Office |
| Location |
| Montreal Regional Service Office |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| Pharmaceutical And Medicine Manufacturing
| N/cons on a "25" old for "1" new basis, "ILE.H" TO "LSL" from NEX to TSX Venture eff 1Mar2023
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| LSL | LSL Pharma Group Inc. | TSX Venture | TRADING |
| LSL.DB | LSL Pharma Group Inc. db31Oct2028 | TSX Venture | TRADING |
|
|
| Name History | From | To |
| LSL Pharma Group Inc. | 1/Mar/2023 | Present |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Spring 2015 CFR | Not Received |
|
|
|
|
|
